Effectiveness of the CoronaVac vaccine in older adults during a gamma variant associated epidemic of covid-19 in Brazil: test negative case-control study
Objective To estimate the effectiveness of the inactivated whole virus vaccine, CoronaVac
(Sinovac Biotech), against symptomatic covid-19 in the elderly population of São Paulo …
(Sinovac Biotech), against symptomatic covid-19 in the elderly population of São Paulo …
[HTML][HTML] Effectiveness of CoronaVac among healthcare workers in the setting of high SARS-CoV-2 Gamma variant transmission in Manaus, Brazil: A test-negative …
MDT Hitchings, OT Ranzani, MSS Torres… - The Lancet Regional …, 2021 - thelancet.com
Background Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variant,
Gamma, emerged in the city of Manaus in late 2020 during a large resurgence of …
Gamma, emerged in the city of Manaus in late 2020 during a large resurgence of …
Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine (CoronaVac) in healthy adults aged 60 years and older: a randomised, double-blind …
Z Wu, Y Hu, M Xu, Z Chen, W Yang, Z Jiang… - The Lancet Infectious …, 2021 - thelancet.com
Background A vaccine against COVID-19 is urgently needed for older adults, in whom
morbidity and mortality due to the disease are increased. We aimed to assess the safety …
morbidity and mortality due to the disease are increased. We aimed to assess the safety …
[HTML][HTML] Immunogenicity and safety of a third dose of CoronaVac, and immune persistence of a two-dose schedule, in healthy adults: interim results from two single …
G Zeng, Q Wu, H Pan, M Li, J Yang, L Wang… - The Lancet Infectious …, 2022 - thelancet.com
Background Large-scale vaccination against COVID-19 is being implemented in many
countries with CoronaVac, an inactivated vaccine. We aimed to assess the immune …
countries with CoronaVac, an inactivated vaccine. We aimed to assess the immune …
[HTML][HTML] Effectiveness of CoronaVac in the setting of high SARS-CoV-2 P. 1 variant transmission in Brazil: A test-negative case-control study
MDT Hitchings, OT Ranzani, MSS Torres… - MedRxiv, 2021 - medrxiv.org
Background Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variant P. 1
emerged in the city of Manaus in late 2020 during a large resurgence of coronavirus disease …
emerged in the city of Manaus in late 2020 during a large resurgence of coronavirus disease …
[HTML][HTML] Safety of an inactivated, whole-virion COVID-19 vaccine (CoronaVac) in people aged 60 years or older in Hong Kong: a modified self-controlled case series
Background Because evidence on the safety of COVID-19 vaccines in older adults is scarce,
we aimed to evaluate the incidence and risk of adverse events after CoronaVac (Sinovac …
we aimed to evaluate the incidence and risk of adverse events after CoronaVac (Sinovac …
[HTML][HTML] Heterologous versus homologous COVID-19 booster vaccination in previous recipients of two doses of CoronaVac COVID-19 vaccine in Brazil (RHH-001): a …
SAC Clemens, L Weckx, R Clemens, AVA Mendes… - The Lancet, 2022 - thelancet.com
Introduction The inactivated whole-virion SARS-CoV-2 vaccine (CoronaVac, Sinovac) has
been widely used in a two-dose schedule. We assessed whether a third dose of the …
been widely used in a two-dose schedule. We assessed whether a third dose of the …
[HTML][HTML] Effectiveness of the first component of Gam-COVID-Vac (Sputnik V) on reduction of SARS-CoV-2 confirmed infections, hospitalisations and mortality in …
S González, S Olszevicki, M Salazar, A Calabria… - …, 2021 - thelancet.com
Background A first-dose of various vaccines provides acceptable protection against
infections by SARS-CoV-2 and evolution to the most severe forms of COVID-19. The …
infections by SARS-CoV-2 and evolution to the most severe forms of COVID-19. The …
[HTML][HTML] Duration of protection of CoronaVac plus heterologous BNT162b2 booster in the Omicron period in Brazil
T Cerqueira-Silva, V de Araujo Oliveira… - Nature …, 2022 - nature.com
To date, no information has been published on the effectiveness of inactivated whole-virus
COVID-19 vaccines plus heterologous booster against symptomatic infection and severe …
COVID-19 vaccines plus heterologous booster against symptomatic infection and severe …
Efficacy and safety of a COVID-19 inactivated vaccine in healthcare professionals in Brazil: the PROFISCOV study
R Palacios, AP Batista, CSN Albuquerque, EG Patiño… - 2021 - papers.ssrn.com
Background: Vaccines are urgently needed to tackle the unprecedented morbidity and
mortality of COVID-19. Administration of inactivated viruses are the common and mature …
mortality of COVID-19. Administration of inactivated viruses are the common and mature …